Cargando…
Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
Triple negative breast cancer (TNBC) is a heterogeneous subset of breast cancer characterized by its lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), which altogether prevents TNBC from being treated effectively. For many years, the treatment par...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522541/ https://www.ncbi.nlm.nih.gov/pubmed/33024896 http://dx.doi.org/10.1016/j.bioactmat.2020.09.016 |